Mostrando 2 resultados de: 2
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
ArticleAbstract: The Hippo signaling pathway and its two downstream effectors, the YAP and TAZ transcriptional coactiPalabras claves:Autores:Aerts S., Algueró-Nadal A., Castaldo S.A., de Waegeneer M., Halder G., Hillen H., Iván M. Moya, Jacobs J., Johnson R.L., Karaman R., Karras P., Kowalczyk W., Mannaerts I., Marine J.C., Roskams T., Sansores-Garcia L., Soheily S., Van den Mooter L., van Grunsven L.A., van Haele M., Van Huffel L., Verboven E., Verhulst S., Xie J., Zender L.Fuentes:googlescopusYAP and TAZ heterogeneity in primary liver cancer: An analysis of its prognostic and diagnostic role
ArticleAbstract: Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors isPalabras claves:CCA, CHCC-CCA, HCC, Hepatic progenitor cells, Keratin 19, TAZ, YAPAutores:Govaere O., Halder G., Iván M. Moya, Karaman R., Monbaliu D., Nevens F., Rens G., Roskams T., Snoeck J., Topal B., van Haele M., Verslype C.Fuentes:googlescopus